Dry powder inhalation (DPI) formulations demand tight particle size control and high batch consistency. Munit provides GMP-compliant particle engineering for inhalation APIs, offering custom micronization, co-micronization, and analytical support.
DPI-Specific Particle Size Requirements
For inhaled drugs, achieving particles in the 1–5 micron range is essential to ensure lung deposition and therapeutic efficacy. Munit applies precision jet milling and real-time analytics to meet aerodynamic and geometric PSD targets.
Co-Micronization and Carrier Integration
We offer co-micronization services to optimize API-excipient interaction, commonly used in lactose-based DPI systems. This improves flowability, dosing consistency, and powder dispersion during inhalation.
Analytical and Regulatory Integration
Each inhalation project includes PSD analysis, blend homogeneity testing, and cleaning validation. We support method development and regulatory documentation aligned with EMA and FDA expectations for inhalation products.
Develop better inhalation therapies with tailored particle control.
Discover DPI micronization solutions at Munit.